PC
BDSI

PointState Capital’s BioDelivery Sciences International, Inc. BDSI Stock Holding History

PointState Capital’s Portfolio BDSI Stock Details BDSI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-350,000
Closed -$3.67M – 191
2015
Q1 		$3.67M Buy
+350,000
New +$4.78M 0.05% 100

Other funds holding BDSI

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
EAM
EverPoint Asset Management Stamford, Connecticut $5.38B AUM 21.45% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PCM
Penn Capital Management Philadelphia, Pennsylvania $1.29B AUM 53.44% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

PointState Capital's BDSI Position: Q2 2015 in Review

PointState Capital sold out of BioDelivery Sciences International, Inc. (BDSI) in Q2 2015, closing a stake of 350,000 shares — an estimated $3.67M sold.

PointState Capital first reported a position in BDSI in Q1 2015 and held it in 1 quarter. The position peaked at $3.67M in Q1 2015. 143 funds tracked by Wall St. Rank hold BDSI as of Q2 2015.

  • PointState Capital reported no remaining BioDelivery Sciences International, Inc. position as of Q2 2015 after selling out during the quarter.
  • PointState Capital sold 350,000 BioDelivery Sciences International, Inc. shares in Q2 2015, an estimated $3.67M.
  • PointState Capital first reported a position in BioDelivery Sciences International, Inc. in Q1 2015 and held it in 1 quarter.
  • PointState Capital's BioDelivery Sciences International, Inc. position peaked at $3.67M in Q1 2015.
  • 143 funds tracked by Wall St. Rank held BioDelivery Sciences International, Inc. as of Q2 2015.

Based on PointState Capital's 13F filing for Q2 2015, filed 14 Aug 2015.